Skip to main content
SpringerLink
Log in

A Review of Non-Hormonal Options for the Relief of Menopausal Symptoms

  • Review Article
  • Published:
Treatments in Endocrinology

Abstract

The climacteric syndrome involves a variety of symptoms such as profuse sweating, insomnia, memory loss, decreased sexual drives, joint aches, and anxiety. However, amongst these symptoms, hot flashes and sweats are generally considered the hallmark and result in the majority of the medical consultations for this condition. Hot flashes are known to respond readily to placebo, which alone decreases their frequency by 20–40%. In the ideal setting of clinical trials, with optimal patient selection and compliance, estrogen therapy reduces hot flashes by about 70–80%; this is twice as effective as placebo. However, estrogen is unable to be universally used, either because of contraindications or because of an unwillingness of women to take it. Furthermore, hot flashes may persist in spite of adequate estrogen replacement, and physicians are often faced with the dilemma of finding something to administer in place of, or in addition to, estrogen to improve symptoms. The most commonly used non-hormonal alternatives for climacteric symptoms are neurotransmitter modulators such as serotonin reuptake inhibitors and gabapentin. These are, at best, approximately half as effective as estrogen for the relief of menopausal symptoms, and are only marginally better than placebo.

Complementary treatment, particularly over-the-counter phytotherapeutic extracts, are very popular and women often try a variety of such products before resorting to conventional medicine. Preparations containing isoflavones, such as soy extract and red clover or extracts from evening primrose or cimicifuga (black cohosh, Actaea racemosa, syn. Cimicifuga racemosa), in variable doses are very popular for the treatment of hot flashes. The scientific support for their efficacy certainly does not equal their popularity.

Non-hormonal treatments for menopause are not as effective as estrogens in relieving hot flashes, but may have a role in therapy for women who have contraindications to gonadal steroid use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III

Similar content being viewed by others

References

  1. Casper RF, Graves GR, Reid RL. Objective measurement of hot flushes associated with the premenstrual syndrome. Fertil Steril 1987; 2: 341–4

    Google Scholar 

  2. Sievert LL, Flanagan EK. Geographical distribution of hot flash frequencies: considering climatic influences. Am J Phys Anthropol 2005; 128: 437–43

    Article  PubMed  Google Scholar 

  3. Gracia CR, Freeman EW. Acute consequences of the menopausal transition: the rise of common menopausal symptoms. Endocrinol Metab Clin North Am 2004; 33: 675–89

    Article  PubMed  CAS  Google Scholar 

  4. Kang HJ, Ansbacher R, Hammoud MM. Use of alternative and complementary medicine in menopause. Int J Gynaecol Obstet 2002; 79: 195–207

    Article  PubMed  CAS  Google Scholar 

  5. North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of the North American Menopause Society. Menopause 2004; 11: 11–33

    Article  Google Scholar 

  6. Seidl MM, Stewart DE. Alternative treatments for menopausal symptoms: systematic review of scientific and lay literature. Can Fam Physician 1998; 44: 1299–308

    PubMed  CAS  Google Scholar 

  7. Kessler DA. Cancer and herbs. N Engl J Med 2000; 342: 1742–3

    Article  PubMed  CAS  Google Scholar 

  8. Kassler WJ, Blanc P, Greenblatt R. The use of medicinal herbs by human immunodeficiency virus infected patients. Arch Intern Med 1991; 151: 2281–8

    Article  PubMed  CAS  Google Scholar 

  9. D’Arcy PF. Adverse reactions and interactions with herbal medicine. Adverse Drug React Toxicol Rev 1991; 10: 189–208

    PubMed  Google Scholar 

  10. Sampson W. Studying herbal remedies. N Engl J Med 2005; 353: 337–9

    Article  PubMed  CAS  Google Scholar 

  11. Meydani M, Meydani M. Nutrition interventions in aging and age-associated disease. Proc Nutr Soc 2002; 2: 165–71

    Article  Google Scholar 

  12. Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005; 293: 1338–47

    Article  PubMed  Google Scholar 

  13. Barton DL, Loprinzi CL, Quella SK, et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 1998 Feb; 16(2): 495–500

    PubMed  CAS  Google Scholar 

  14. Chenoy R, Hussain S, Tayob Y, et al. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ 1994; 308: 501–3

    Article  PubMed  CAS  Google Scholar 

  15. Ellis JM, Reddy P. Effects of panax ginseng on quality of life. Ann Pharmacother 2002; 36: 375–9

    Article  PubMed  Google Scholar 

  16. Persson J, Bringlov E, Nilsson LG, et al. The memory-enhancing effects of ginseng and ginkgo biloba in healthy volunteers. Psychopharmacology (Berl) 2004; 172: 430–4

    Article  CAS  Google Scholar 

  17. Solomon PR, Adams F, Silver A, et al. Ginkgo for memory enhancement: a randomized controlled trial. JAMA 2002; 288: 835–40

    Article  PubMed  Google Scholar 

  18. Hartley DE, Elsabagh S, File SE. Gincosan (a combination of ginkgo biloba and panax ginseng): the effects on mood and cognition of 6 and 12 weeks’ treatment in post-menopausal women. Nutr Neurosci 2004; 7: 325–33

    Article  PubMed  CAS  Google Scholar 

  19. Sun J. Morning/evening menopausal formula relieves menopausal symptoms: a pilot study. J Altern Complement Med 2003; 9: 403–9

    Article  PubMed  Google Scholar 

  20. Wiklund IK, Mattsson LA, Lindgren R, et al. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic post-menopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group. Int J Clin Pharmacol Res 1999; 19: 89–99

    PubMed  CAS  Google Scholar 

  21. Polan ML, Hochberg RB, Trant AS, et al. Estrogen bioassay of ginseng extract and ArginMax™, a nutritional supplement for the enhancement of female sexual function. J Womens Health (Larchmt) 2004; 13: 427–30

    Article  Google Scholar 

  22. Zell B, Hirata J, Marcus A, et al. Diagnosis of symptomatic postmenopausal women by traditional Chinese medicine practitioners. Menopause 2000; 2: 129–34

    Article  Google Scholar 

  23. Davis SR, Briganti EM, Chen RQ, et al. The effects of Chinese medicinal herbs on postmenopausal vasomotor symptoms of Australian women: a randomised controlled trial. Med J Aust 2001; 174: 68–71

    PubMed  CAS  Google Scholar 

  24. Setchell KD. Soy isoflavones: benefits and risks from nature’s selective estrogen receptor modulators (SERMs). J Am Coll Nutr 2001; 20(5 Suppl.): 354S–62S

    PubMed  CAS  Google Scholar 

  25. Murkies AL, Lombard C, Strauss BJG, et al. Dietary flower supplementation decreases post-menopasual hot flushes: effect of soy and wheat. Maturitas 1995; 21: 189–95

    Article  PubMed  CAS  Google Scholar 

  26. Brzezinski A, Adlercreutz H, Shaoul R, et al. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 1997; 4: 89–94

    Article  Google Scholar 

  27. Albertazzi P, Pansini F, Bonaccorsi G, et al. The effect of soy supplementation on hot flushes. Obstet Gynecol 1998; 91: 6–11

    Article  PubMed  CAS  Google Scholar 

  28. Washburn S, Burke GL, Morgan T, et al. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999; 6: 7–13

    Article  PubMed  CAS  Google Scholar 

  29. Scambia G, Mango D, Signorile PG, et al. Clinical effects of a standardized soy extract in postmenopasual women: a pilot study. Menopause 2000; 2: 105–11

    Article  Google Scholar 

  30. Han KK, Soares Jr JM, Haidar MA, et al. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol 2002; 99: 389–94

    Article  PubMed  CAS  Google Scholar 

  31. Upmalis DH, Lobo R, Bradley L, et al. Vasomotor symptoms relief by soy isoflavone extract tablets in postmenopausal women; a multicenter, double-blind, randomized, placebo-controlled study. Menopause 2000; 7: 236–42

    Article  PubMed  CAS  Google Scholar 

  32. Faure ED, Chantre P, Mares P. Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 2002; 9: 329–34

    Article  PubMed  Google Scholar 

  33. Petri Nahas E, Nahas Neto J, De Luca L, et al. Benefit of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy. Maturitas 2004; 48: 372–80

    Article  PubMed  CAS  Google Scholar 

  34. Sammartino A, Di Carlo C, Mandate VD, et al. Effects of genistein on the endometrium: ultrasonographic evaluation. Gynecol Endocrinol 2003; 17: 45–9

    PubMed  CAS  Google Scholar 

  35. Crisafulli A, Marini H, Bitto A, et al. Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study. Menopause 2004; 11: 400–4

    Article  PubMed  Google Scholar 

  36. van de Weijer PH, Barentsen R. Isoflavones from red clover (Promensil™) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002; 42: 187–93

    Article  PubMed  Google Scholar 

  37. Dalais FS, Rice GE, Wahlqvist ML, et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1998; 1: 124–9

    Article  PubMed  CAS  Google Scholar 

  38. Knight DC, Howes JB, Eden JA, et al. Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation. Climacteric 2001; 4: 13–8

    PubMed  CAS  Google Scholar 

  39. Kotsopoulos D, Dalais FS, Liang YL, et al. The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric 2000; 316: 161–7

    Article  Google Scholar 

  40. St Germain A, Peterson CT, Robinson JG, et al. Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause 2001; 8: 17–26

    Article  Google Scholar 

  41. Burke GL, Legault C, Anthony M, et al. Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study. Menopause 2003; 10: 147–53

    Article  PubMed  Google Scholar 

  42. Van Patten CL, Olivotto IA, Chambers GK, et al. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J Clin Oncol 2002; 20: 1449–55

    Article  PubMed  Google Scholar 

  43. Quella SK, Loprinzi CL, Barton DL, et al. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment Group trial. J Clin Oncol 2000; 5: 1068–74

    Google Scholar 

  44. Nikander E, Kilkkinen A, Metsa-Heikkila M, et al. A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet Gynecol 2003 Jun; 101(6): 1213–20

    Article  PubMed  CAS  Google Scholar 

  45. Penotti M, Fabio E, Modena AB, et al. Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries. Fertil Steril 2003; 79: 1112–7

    Article  PubMed  Google Scholar 

  46. MacGregor C, Canney P, Patterson G, et al. A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer. Eur J Cancer 2005; 41: 708–14

    Article  PubMed  CAS  Google Scholar 

  47. Baber RJ, Templeman C, Morton T, et al. Randomised placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999; 2: 85–92

    Article  PubMed  CAS  Google Scholar 

  48. Knight DC, Howes JB. Eden JA. The effects of Promensil™ an isoflavone extract on menopausal symptoms. Climacteric 1999; 2: 79–84

    Article  PubMed  CAS  Google Scholar 

  49. Tice JA, Ettinger B, Ensrud K, et al. Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study: a randomized controlled trial. JAMA 2003; 290: 207–14

    Article  PubMed  CAS  Google Scholar 

  50. Ernst E. Herbalism and the menopause. J Br Menopause Soc 2002; 8: 72–4

    Google Scholar 

  51. Ernst E. Herbal remedies as a treatment of some frequent symptoms during menopause. J Br Menopause Soc 1999; 5: 117–20

    Google Scholar 

  52. Mackey R, Eden J. Phytoestrogens. J Br Menopause Soc 1998; 4: 18–23

    Google Scholar 

  53. Phytohealth [online]. Available from URL: http://www.phytohealth.org [Accessed 2005 Nov]

  54. Graves AB, Larson EB, Edland SD, et al. Prevalence of dementia and its subtypes in the Japanese American population of King country, Washington state. Am J Epidemiol 1996; 144: 760–1

    Article  PubMed  CAS  Google Scholar 

  55. White LR, Petrovitch H, Ross GW, et al. Brain ageing and midlife tofu consumption. J Am Coll Nutr 2000; 19: 242–55

    PubMed  CAS  Google Scholar 

  56. Kritz-Silverstein D, Von Muhlen D, Barrett-Connor E, et al. Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) study. Menopause 2003; 10: 196–202

    Article  PubMed  Google Scholar 

  57. File SE, Jarret N, Fluck E, et al. Eating soya improves human memory. Psychopharmacology 2001; 157: 430–6

    Article  PubMed  CAS  Google Scholar 

  58. Kreijkamp-Kaspers S, Kok L, Grobbee DE, et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 2004; 292: 65–74

    Article  PubMed  CAS  Google Scholar 

  59. Howes JB, Bray K, Lorenz L, et al. The effects of dietary supplementation with isoflavones from red clover on cognitive function in postmenopausal women. Climacteric 2004; 7: 70–7

    Article  PubMed  CAS  Google Scholar 

  60. Albertazzi P. Soy supplements: why is effect so elusive? [letter]. J Clin Endocrinol Metab 2002; 87: 5308

    Article  Google Scholar 

  61. Mahady GB. Black cohosh (Actaea/Cimicifuga racemosa): review of the clinical data for safety and efficacy in menopausal symptoms. Treat Endocrinol 2005; 4: 177–84

    Article  PubMed  Google Scholar 

  62. Duker E, Kopanski L, Jarry H, et al. Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Med 1991; 57: 420–4

    Article  PubMed  CAS  Google Scholar 

  63. Liske E, Wustenberg P. Therapy of climacteric complaints with Cimicifuga racemosa, a herbal medicine with clinically proven evidence [abstract]. Menopause 1998; 5: 250

    Article  Google Scholar 

  64. Liske E, Wustenberg P, Boblitz N. Human pharmacological investigations during treatment of climacteric complaints with Cimicifuga racemosa (Remifemin®): no estrogen-like effects [poster]. The European Phytojournal 1998; 1 (1)

  65. Einer-Jensen N, Zhao J, Andersen K, et al. Cimicifuga and melbrosia lack oestrogenic effects in mice and rats. Maturitas 1996; 25: 149–53

    Article  PubMed  CAS  Google Scholar 

  66. Wuttke W, Seidlova-Wuttke D, Gorkov C. The cimicifuga preparation BNO 1055 vs conjugated estrogens in a double blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 2003; 44Suppl. 1: S67–77

    Article  PubMed  Google Scholar 

  67. Osmers R, Friede M, Liske E, et al. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol 2005; 105 (5 Pt 1): 1074–83

    Article  PubMed  Google Scholar 

  68. Jacobson JS, Troxel AB, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001; 19: 2739–45

    PubMed  CAS  Google Scholar 

  69. Frei-Kleiner S, Schaffner W, Rahlfs VW, et al. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Maturitas 2005; 51: 397–404

    Article  PubMed  CAS  Google Scholar 

  70. Verhoeven MO, van der Mooren MJ, van de Weijer PH, et al. Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind study. Menopause 2005; 12: 412–20

    Article  PubMed  Google Scholar 

  71. Hirata JD, Swiersz LM, Zell B, et al. Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril 1997; 68: 981–6

    Article  PubMed  CAS  Google Scholar 

  72. Folsom AR, Demissie Z. Fish intake, marine omega-3 fatty acids, and mortality in a cohort of postmenopausal women. Am J Epidemiol 2004; 160: 1005–10

    Article  PubMed  Google Scholar 

  73. Nkondjock A, Ghadirian P. Intake of specific carotenoids and essential fatty acids and breast cancer risk in Montreal, Canada. Am J Clin Nutr 2004; 79: 857–64

    PubMed  CAS  Google Scholar 

  74. Fernandes G, Lawrence R, Sun D. Protective role of n-3 lipids and soy protein in osteoporosis. Prostaglandins Leukot Essent Fatty Acids 2003; 68: 361–72

    Article  PubMed  CAS  Google Scholar 

  75. Campagnoli C, Abba C, Ambroggio S, et al. Polyunsaturated fatty acids (PUFAs) might reduce hot flushes: an indication from two controlled trials on soy isoflavones alone and with a PUFA supplement. Maturitas 2005; 51: 127–34

    Article  PubMed  CAS  Google Scholar 

  76. Berendsen HHG. Hot flushes and serotonin. J Br Menopause Soc 2002; 8: 30–4

    Google Scholar 

  77. Pandya KJ, Raubertas RF, Flynn PJ, et al. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study. Ann Intern Med 2000; 132: 788–93

    PubMed  CAS  Google Scholar 

  78. Wesel S, Bourguignon RP, Bosuma WB. Veralipride versus conjugated oestrogens: a double-blind study in the management of menopausal hot flushes. Curr Med Res Opin 1984; 8: 696–700

    Article  PubMed  CAS  Google Scholar 

  79. Guttuso Jr T, Kurlan R, McDermott MP, et al. Gabapentin’s effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003; 101: 337–45

    Article  PubMed  CAS  Google Scholar 

  80. Pandya KJ, Morrow GR, Roscoe JA, et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet 2005; 366: 818–24

    Article  PubMed  CAS  Google Scholar 

  81. Evans ML, Pritts E, Vittinghoff E, et al. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol 2005; 105: 161–6

    Article  PubMed  CAS  Google Scholar 

  82. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000; 356: 2059–63

    Article  PubMed  CAS  Google Scholar 

  83. Biglia N, Torta R, Roagna R, et al. Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors. Maturitas 2005; 52: 78–85

    Article  PubMed  CAS  Google Scholar 

  84. Loprinzi CL, Sloan JA, Perez EA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002; 20: 1578–83

    Article  PubMed  CAS  Google Scholar 

  85. Stearns V, Beebe KL, Iyengar M, et al. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA 2003; 289: 2827–34

    Article  PubMed  CAS  Google Scholar 

  86. Goldberg RM, Loprinzi CL, O’Fallon JR, et al. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes [published erratum appears in J Clin Oncol 1996; 14: 2411]. J Clin Oncol 1994; 12: 155–8

    PubMed  CAS  Google Scholar 

  87. Verbeke K, Dhont M, Vandekerckhove D. Clinical and hormonal effects of long-term veralipride treatment in post-menopausal women. Maturitas 1988; 10: 225–30

    Article  PubMed  CAS  Google Scholar 

  88. Guttuso Jr TJ. Gabapentin’s effects on hot flashes and hypothermia. Neurology 2000; 54: 2161–3

    Article  PubMed  Google Scholar 

  89. Albertazzi P, Bottazzi M, Purdie DW. Gabapentin for the management of hot flushes: a case series. Menopause 2003; 10: 214–7

    Article  PubMed  Google Scholar 

  90. Berendsen HH. The role of serotonin in hot flushes. Maturitas 2000; 36: 155–64

    Article  PubMed  CAS  Google Scholar 

  91. Weitzner MA, Moncello J, Jacobsen PB, et al. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Symptom Manage 2002; 4: 337–45

    Article  Google Scholar 

  92. Pansini F, Albertazzi P, Bonaccorsi G, et al. Trazodone: a non-hormonal alternative for neurovegetative climacteric symptoms. Clin Exp Obstet Gynecol 1995; 22: 341–4

    PubMed  CAS  Google Scholar 

  93. Barton DL, Loprinzi CL, Novotny P, et al. Pilot evaluation of citalopram for the relief of hot flashes. J Support Oncol 2003; 1: 47–51

    PubMed  CAS  Google Scholar 

  94. Waldinger MD, Berendsen HH, Schweitzer DH. Treatment of hot flushes with mirtazapine: four case reports. Maturitas 2000; 36: 165–8

    Article  PubMed  CAS  Google Scholar 

  95. Haddad PM. Do antidepressants cause dependence? Epidemiol Psichiatr Soc 2005; 14: 58–62

    Article  PubMed  Google Scholar 

  96. Coope J, Williams S, Patterson JS. A study of the effectiveness of propranolol in menopausal hot flushes. Br J Obstet Gynaecol 1978; 6: 472–5

    Google Scholar 

  97. Alcoff JM, Campbell D, Tribble D, et al. Double-blind, placebo-controlled, crossover trial of propranolol as treatment for menopausal vasomotor symptoms. Clin Ther 1981; 5: 356–64

    Google Scholar 

  98. Shaw CR. The perimenopausal hot flush: epidemiology, physiology and treatment. Nurse Pract 1997; 55: 61–6

    Google Scholar 

  99. Hammar M, Berg G, Lindgren R. Does physical exercise influence the frequency of postmenopausal hot flushes? Acta Obstet Gynecol Scand 1990; 69(5): 409–12

    Article  PubMed  CAS  Google Scholar 

  100. Slaven L, Lee C. Mood and symptom reporting among middle-aged women: the relationship between menopausal status, hormone replacement therapy, and exercise participation. Health Psychol 1997; 16: 203–8

    Article  PubMed  CAS  Google Scholar 

  101. Lindh-Astrand L, Nedstrand E, Wyon Y, et al. Vasomotor symptoms and quality of life in previously sedentary postmenopausal women randomised to physical activity or estrogen therapy. Maturitas 2004; 48: 97–105

    Article  PubMed  CAS  Google Scholar 

  102. Ivarsson T, Spetz AC, Hammar M. Physical exercise and vasomotor symptoms in postmenopausal women. Maturitas 1998; 29: 139–46

    Article  PubMed  CAS  Google Scholar 

  103. Nedstrand E, Wijma K, Wyon Y, et al. Applied relaxation and oral estradiol treatment of vasomotor symptoms in postmenopausal women. Maturitas 2005; 51: 154–62

    Article  PubMed  CAS  Google Scholar 

  104. Hunter MS. A treatment option for menopausal hot flushes: cognitive relaxation therapy. Eur Menopause J 1995; 2: 16–7

    Google Scholar 

  105. Stevenson DW, Delprato DJ. Multiple component self-control program for menopausal hot flashes. J Behav Ther Exp Psychiatry 1983; 2: 137–40

    Article  Google Scholar 

  106. Wijma K, Melin A, Nedstrand E, et al. Treatment of menopausal symptoms with applied relaxation: a pilot study. J Behav Ther Exp Psychiatry 1997; 28: 251–61

    Article  PubMed  CAS  Google Scholar 

  107. Freedman RR, Woodward S. Behavioural treatment of menopausal hot flushes: evaluation of ambulatory monitoring. Am J Obstet Gynecol 1992; 167: 436–9

    PubMed  CAS  Google Scholar 

  108. Carpenter JS, Wells N, Lambert B, et al. A pilot study of magnetic therapy for hot flashes after breast cancer. Cancer Nurs 2002; 25: 104–9

    Article  PubMed  Google Scholar 

  109. Porzio G, Trapasso T, Martelli S, et al. Acupuncture in the treatment of menopause-related symptoms in women taking tamoxifen. Tumori 2002; 88: 128–30

    PubMed  Google Scholar 

  110. Dong H, Ludicke F, Comte I, et al. An exploratory pilot study of acupuncture on the quality of life and reproductive hormone secretion in menopausal women. J Altern Complement Med 2001 Dec; 7(6): 651–8

    Article  PubMed  CAS  Google Scholar 

  111. Wyon Y, Wijma K, Nedstrand E, et al. A comparison of acupuncture and oral estradiol treatment of vasomotor symptoms in postmenopausal women. Climacteric 2004; 7: 153–64

    Article  PubMed  CAS  Google Scholar 

  112. Nedstrand E, Wijma K, Wyon Y, et al. Vasomotor symptoms decrease in women with breast cancer randomized to treatment with applied relaxation of electroacupunture: a preliminary study. Climacteric 2005; 8: 243–50

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Metabolic Bone Disease, Hull Royal Infirmary, Hull, HU3 2RW, UK

    Paola Albertazzi

Authors
  1. Paola Albertazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paola Albertazzi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Albertazzi, P. A Review of Non-Hormonal Options for the Relief of Menopausal Symptoms. Mol Diag Ther 5, 101–113 (2006). https://doi.org/10.2165/00024677-200605020-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00024677-200605020-00004

Keywords

Search

Navigation